Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B.
Saved in:
| Title: | Transcriptomic profiling of adjuvant colorectal cancer identifies three key prognostic biological processes and a disease specific role for granzyme B. |
|---|---|
| Authors: | Daemen A; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America., Udyavar AR; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America., Sandmann T; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America., Li C; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Bosch LJW; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., O'Gorman W; OMNI Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Li Y; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Au-Yeung A; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Takahashi C; OMNI Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Kabbarah O; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Bourgon R; Bioinformatics & Computational Biology, Genentech Inc., South San Francisco, California, United States of America., Hegde P; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Bais C; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America., Das Thakur M; Oncology Biomarker Development, Genentech Inc., South San Francisco, California, United States of America. |
| Source: | PloS one [PLoS One] 2021 Dec 31; Vol. 16 (12), pp. e0262198. Date of Electronic Publication: 2021 Dec 31 (Print Publication: 2021). |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1932-6203 |
|---|---|
| DOI: | 10.1371/journal.pone.0262198 |
